REVIEW 2 cited by
CCPL: Cross-modal Contrastive Protein Learning
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
Effective protein representation learning is crucial for predicting protein functions. Traditional methods often pretrain protein language models on large, unlabeled amino acid sequences, followed by finetuning on labeled data. While effective, these methods underutilize the potential of protein structures, which are vital for function determination. Common structural representation techniques rely heavily on annotated data, limiting their generalizability. Moreover, structural pretraining methods, similar to natural language pretraining, can distort actual protein structures. In this work, we introduce a novel unsupervised protein structure representation pretraining method, cross-modal contrastive protein learning (CCPL). CCPL leverages a robust protein language model and uses unsupervised contrastive alignment to enhance structure learning, incorporating self-supervised structural constraints to maintain intrinsic structural information. We evaluated our model across various benchmarks, demonstrating the framework's superiority.
Forward citations
Cited by 2 Pith papers
-
DapPep: Domain Adaptive Peptide-agnostic Learning for Universal T-cell Receptor-antigen Binding Affinity Prediction
DapPep, built from ESM-2 with cross-attention and peptide-reconstruction pre-training, reports ROC-AUC 0.816 and PR-AUC 0.836 on unseen peptides, beating PanPep by about 9 to 11 percent.
-
Pan-protein Design Learning Enables Task-adaptive Generalization for Low-resource Enzyme Design
CrossDesign aligns pretrained protein language models with structure encoders to improve enzyme sequence design and zero-shot mutation fitness prediction.
Discussion (0). Continue with ORCID to comment.